ERDEM, S. Et Al. 2015. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma. WORLD JOURNAL OF UROLOGY , vol.33, no.10 , 1553-1560.

ERDEM, S., YEGEN, G., Telci, D., YILDIZ, İ., TEFIK, T., İŞSEVER, H., ... KILIÇASLAN, I.(2015). The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma. WORLD JOURNAL OF UROLOGY , vol.33, no.10, 1553-1560.

ERDEM, Selçuk Et Al. "The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma," WORLD JOURNAL OF UROLOGY , vol.33, no.10, 1553-1560, 2015

ERDEM, Selçuk Et Al. "The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma." WORLD JOURNAL OF UROLOGY , vol.33, no.10, pp.1553-1560, 2015

ERDEM, S. Et Al. (2015) . "The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma." WORLD JOURNAL OF UROLOGY , vol.33, no.10, pp.1553-1560.

@article{article, author={Selçuk ERDEM Et Al. }, title={The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma}, journal={WORLD JOURNAL OF UROLOGY}, year=2015, pages={1553-1560} }